Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

Mostrar otras versiones (1)

BACKGROUND: Effective therapeutics to treat COVID-19 are urgently needed. Remdesivir is a nucleotide prodrug with in vitro and in vivo efficacy against coronaviruses. Here, we tested the efficacy of remdesivir treatment in a rhesus macaque model of SARS-CoV-2 infection. METHODS: To evaluate the effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Williamson, Brandi N., Feldmann, Friederike, Schwarz, Benjamin, Meade-White, Kimberly, Porter, Danielle P., Schulz, Jonathan, van Doremalen, Neeltje, Leighton, Ian, Kwe Yinda, Claude, Pérez-Pérez, Lizzette, Okumura, Atsushi, Lovaglio, Jamie, Hanley, Patrick W., Saturday, Greg, Bosio, Catharine M., Anzick, Sarah, Barbian, Kent, Cihlar, Tomas, Martens, Craig, Scott, Dana P., Munster, Vincent J., de Wit, Emmie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239049/
https://www.ncbi.nlm.nih.gov/pubmed/32511319
http://dx.doi.org/10.1101/2020.04.15.043166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239049/
https://www.ncbi.nlm.nih.gov/pubmed/32511319
http://dx.doi.org/10.1101/2020.04.15.043166

Ejemplares similares